Skip to main content

Table 6 Docking result of a best-docked complex of Crizotinib drug with C-MET, C-ROS1 and ALK proteins

From: Docking and dynamic simulation study of Crizotinib and Temozolomide drug with Glioblastoma and NSCLC target to identify better efficacy of the drug

Protein name

Type of docking

Docking score

Binding energy

(kcal/mol)

Complex energy (kcal/mol)

Interacting residues

DRUG-CRIZOTINIB

2WGJ

PDB(P6)

139.105

− 44.1433

− 11,179.9569

PRO1158, MET1160

3ZBF

MOTIF(P1)

114.545

− 112.0438

− 11,514.2552

ASP2033,GLU2027,MET2029

2XP2

RC(S1,P8)

108.615

− 189.7012

− 11,666.7948

GLU1197, MET1199